亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Salvianolic acid F suppresses KRAS-dependent lung cancer cell growth through the PI3K/AKT signaling pathway

克拉斯 癌症研究 体内 肺癌 PI3K/AKT/mTOR通路 蛋白激酶B 细胞凋亡 细胞生长 癌症 化学 药理学 医学 生物 内科学 结直肠癌 生物化学 生物技术
作者
Xuenan Hou,Chishun Zhou,Zuhui Liang,Huawei Qiu,Z.R. Zhou,Huanjin zheng,Zeyun Li,Ying Wang,Xiaoxiao Qi,Linlin Lu,Yang Cao,Jing Zheng
出处
期刊:Phytomedicine [Elsevier]
卷期号:121: 155093-155093 被引量:7
标识
DOI:10.1016/j.phymed.2023.155093
摘要

KRAS mutation is a common driver of NSCLC, and there is a high proportion of lung cancer patients with KRAS G12C and G12D mutation. KRAS was previously considered an "undruggable" target, but the first KRAS G12C mutation-targeted drug AMG510, entered the market in 2021. However, treatments for G12D mutant tumors remain to be discovered. Salvianolic acid F (SalF), a monomer derived from the traditional Chinese medicine Salvia miltiorrhiza (SM), and KRAS had high binding affinity, especially for KRAS G12D. There is an urgent need to investigate effective and safe novel targeted therapies against KRAS G12D-driven NSCLC.To evaluate the anticancer effect of SalF, we used KRAS-overexpressing lung cancer cells in vitro, a subcutaneous transplant tumor model, and KRAS G12D mice model in vivo. Then, the binding effect of SalF and KRAS was investigated using molecular docking, proteolytic assays and protein thermal shift assays. More critically, the PI3K/AKT signaling pathway in the lung was investigated utilizing RT-qPCR and Western Blotting.This is the first study to evaluate the anticancer effect of SalF on KRAS-overexpressing lung cancer cells or KRAS G12D lung tumors in vivo. We demonstrated that SalF inhibits OE-KRAS A549 cell migration, proliferation and promotes apoptosis in vitro. In addition, we used a subcutaneous transplant tumor model to show that SalF suppresses the growth of lung cancer cells in vivo. Interestingly, our group found that SalF was strongly bound to G12D and could decrease the stability and promoted the degradation of the KRAS G12D mutant through molecular docking, proteolytic assays and protein thermal shift assays. Further research demonstrated that in the KrasG12D mice model, after SalF treatment, the number and size of mouse lung tumors were significantly reduced. More importantly, SalF can promote apoptosis by inhibiting downstream PI3K/AKT signaling pathway activation.SalF activated apoptosis signaling pathways, suppressed anti-apoptotic genes, and inhibited lung cancer cell growth. These datas suggested that SalF could effectively inhibit the growth of lung tumors with KRAS G12D mutation. SalF may be a novel inhibitor against KRAS G12D, providing a strong theoretical basis for the clinical treatment of lung cancer with KRAS mutations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助科研通管家采纳,获得10
7秒前
华仔应助科研通管家采纳,获得10
7秒前
Jasper应助繁荣的珊珊采纳,获得30
11秒前
wyj发布了新的文献求助10
18秒前
一只熊完成签到 ,获得积分10
20秒前
云猫完成签到 ,获得积分10
20秒前
21秒前
21秒前
22秒前
专注水池完成签到,获得积分20
24秒前
26秒前
香蕉酸奶发布了新的文献求助10
30秒前
温暖糖豆完成签到 ,获得积分10
30秒前
37秒前
38秒前
40秒前
drake发布了新的文献求助10
42秒前
wrl2023完成签到,获得积分10
44秒前
46秒前
从容芮完成签到,获得积分0
48秒前
忧虑的羊发布了新的文献求助10
50秒前
drake完成签到,获得积分10
55秒前
58秒前
阴阳怪气平宝贝完成签到 ,获得积分10
59秒前
csbj318完成签到 ,获得积分10
1分钟前
所所应助aaaaa采纳,获得50
1分钟前
专注水池关注了科研通微信公众号
1分钟前
大模型应助香蕉酸奶采纳,获得10
1分钟前
ff完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
喵喵完成签到 ,获得积分10
1分钟前
1分钟前
这个手刹不太灵完成签到 ,获得积分10
1分钟前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3136977
求助须知:如何正确求助?哪些是违规求助? 2787960
关于积分的说明 7784018
捐赠科研通 2444003
什么是DOI,文献DOI怎么找? 1299592
科研通“疑难数据库(出版商)”最低求助积分说明 625477
版权声明 600989